Finland - finsk - Fimea (Suomen lääkevirasto)

laboratorios farmacÉuticos rovi s.a. - chrondroitin sulphate sodium (hydrated) - kapseli, kova - 400 mg - kondroitiinisulfaatti

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

natural bio pty limited - bovine sodium chondroitin sulfate,glucosamine sulfate potassium chloride,hydrolysed collagen -

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty limited - glucose -

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

bppr consulting - glucose monohydrate -

Sveits - tysk - Swissmedic (Swiss Agency for Therapeutic Products)

medinova ag - heparinoidum (chondroitini polysulfas) - creme - heparinoidum (chondroitini polysulfas) 3 mg, corresp. 250 u., glycerolum (85 per centum), acidum stearicum, alcoholes adipis lanae, alcohol cetylicus et stearylicus 31.375 mg, vaselinum album, alcohol myristylicus, alcohol isopropylicus, kalii hydroxidum, e 218 1.6 mg, thymolum, propylis parahydroxybenzoas 0.4 mg, aqua purificata, ad unguentum pro 1 g. - venenmittel für den äusserlichen gebrauch - synthetika

Sveits - tysk - Swissmedic (Swiss Agency for Therapeutic Products)

medinova ag - heparinoidum (chondroitini polysulfas) - gel - heparinoidum (chondroitini polysulfas) 3 mg, corresp. 250 u., alcohol isopropylicus, acidum polyacrylicum, propylenglycolum 5 mg, natrii hydroxidum, aqua purificata, ad gelatum pro 1 g. - venenmittel für den äusserlichen gebrauch - synthetika

Sveits - tysk - Swissmedic (Swiss Agency for Therapeutic Products)

medinova ag - heparinoidum (chondroitini polysulfas) - creme - heparinoidum (chondroitini polysulfas) 4.45 mg, corresp. 400 u., glyceroli monostearas emulsifcans, triglycerida media, alcohol myristylicus, isopropylis myristas, bentonitum, alcohol isopropylicus, phenoxyethanolum, imidazolidinylureum, rosmarini aetheroleum, aqua purificata, ad unguentum pro 1 g. - venenmittel für den äusserlichen gebrauch - synthetika

Sveits - tysk - Swissmedic (Swiss Agency for Therapeutic Products)

medinova ag - heparinoidum (chondroitini polysulfas) - gel - gel: heparinoidum (chondroitini polysulfas) 4.45 mg, corresp. 400 u., alcohol isopropylicus, acidum polyacrylicum, propylenglycolum 5 mg, natrii hydroxidum, aqua purificata, ad gelatum pro 1 g. - venenmittel für den äusserlichen gebrauch - synthetika

USA - engelsk - NLM (National Library of Medicine)

sambria pharmaceuticals - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987) - lidocaine hydrochloride anhydrous 40 mg in 1 g - for temporary relief of pain and itching due to minor skin irritation. ​stop use and ask a doctor if ​ • condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days.  discontinue use.